The European Commission approved a contract with German pharmaceutical firm BioNTech and its US partner Pfizer on Wednesday, guaranteeing that the EU would receive 200 million of doses of their experimental coronavirus vaccine and an additional 100 million dozes upon its verification. Pročitaj više
Oglas
Oglas
Oglas
NAJČITANIJE
Oglas
Oglas
Najnovije
Oglas
Oglas